awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33336635-6338A5F5-5897-451C-B31E-731EE2BC8C89
Q33336635-6338A5F5-5897-451C-B31E-731EE2BC8C89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33336635-6338A5F5-5897-451C-B31E-731EE2BC8C89
Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancer.
P577
Q33336635-6338A5F5-5897-451C-B31E-731EE2BC8C89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33336635-6338A5F5-5897-451C-B31E-731EE2BC8C89
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f8d97d68b87f3758d740c3a79a11c11a1500d340
P577
2001-04-01T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
9c41b5c4c966c79b24c6bb90bd001d5c